Type 2 Diabetes Information Center

Empagliflozin Impact on Life Expectancy Examined in T2DM Patients With CVD

Empagliflozin Impact on Life Expectancy Examined in T2DM Patients With CVD

For this analysis, the authors used follow-up data from all 7020 patients included in the EMPA-REG OUTCOME trial to estimate the effect of empagliflozin on all-cause mortality vs placebo over the duration of a patient's lifetime.

Healthday ADA, EASD Issue New Recommendations for Type 2 Diabetes

ADA, EASD Issue New Recommendations for Type 2 Diabetes

Recommendations for the management of type 2 diabetes have been updated, according to a consensus report by the American Diabetes Association and the European Association for the Study of Diabetes.

Healthday Lixisenatide Cuts Kidney Damage in Type 2 Diabetes and Coronary Syndrome

Lixisenatide Cuts Kidney Damage in Type 2 Diabetes and Coronary Syndrome

Lixisenatide reduces progression of urinary albumin-creatinine ratio in patients with macroalbuminuria.

News Lower Hypoglycemia Risk, Greater Weight Loss With SGLT2 Inhibitor, Sulfonylurea in T2D

Lower Hypoglycemia Risk, Greater Weight Loss With SGLT2 Inhibitor, Sulfonylurea in T2D

SGLT-2i exhibited superior effects in terms of weight loss and did not increase the risk for hypoglycemia in dual therapy with sulfonylurea.

Healthday Higher Aldosterone Levels Tied to Incident Type 2 Diabetes Risk

Higher Aldosterone Levels Tied to Incident Type 2 Diabetes Risk

Racial/ethnic differences seen in the association of aldosterone with incident type 2 diabetes.

News WHO Issues Guidelines for Managing Diabetes in Low-Resource Settings

WHO Issues Guidelines for Managing Diabetes in Low-Resource Settings

WHO has developed guidelines for selecting therapy for treatment intensiļ¬cation in type 2 diabetes and on the use of insulin in type 1 and 2 diabetes in resource-poor settings.

News Polypharmacy Therapy for Schizophrenia Increases Risk for Type 2 Diabetes

Polypharmacy Therapy for Schizophrenia Increases Risk for Type 2 Diabetes

Investigators aimed to assess the effect of psychotropic medications, BMI, duration of schizophrenia, number of hospitalizations, and physical activity on the risk for T2D.

Healthday Healthy Lifestyle With Diabetes Cuts Cardiovascular Risk

Healthy Lifestyle With Diabetes Cuts Cardiovascular Risk

Benefit seen for adoption of healthy lifestyle even after T2DM diagnosis made.

Two Minute Medicine

Bariatric surgery linked to significant reduction in microvascular complications of type 2 diabetes

Patients who received gastric bypass surgery had lower rates of diabetic neuropathy at follow up that remained stable throughout the study.

Feature Fasting Insulin vs Hemoglobin A1c: Are We Getting It Right?

Fasting Insulin vs Hemoglobin A1c: Are We Getting It Right?

The early diagnosis and management of prediabetes will have a significant impact on patient outcomes and healthcare spending.

Sign Up for Free e-newsletters